Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-17

FDA Approved: BUMETANIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' bumetanide original application, granting a generic diuretic for edema associated with congestive heart failure, hepatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)